Sorafenib plus transarterial chemoembolization for unresectable hepatocellular carcinoma

被引：1
|
作者：
Tsilimigras, Diamantis I. [1 ]
Pawlik, Timothy M.
机构：
[1] Ohio State Univ, Wexner Med Ctr, Div Surg Oncol, Dept Surg, 410 W 10th Ave,Columbus, Columbus, OH 43210 USA
来源：
ANNALS OF TRANSLATIONAL MEDICINE | 2020年 / 8卷 / 23期
关键词：
ENDOTHELIAL GROWTH-FACTOR; DRUG-ELUTING BEADS; PHASE-III; EXPRESSION; EFFICACY; JAPANESE; TRIAL;
D O I：
10.21037/atm-20-7228
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [31] Transarterial chemoembolization in children to treat unresectable hepatocellular carcinoma
    Weiss, Krista E.
    Sze, Daniel Y.
    Rangaswami, Arun A.
    Esquivel, Carlos O.
    Concepcion, Waldo
    Lebowitz, Edward A.
    Kothary, Nishita
    Lungren, Matthew P.
    PEDIATRIC TRANSPLANTATION, 2018, 22 (04)
  • [32] Sequential transarterial chemoembolization for unresectable advanced hepatocellular carcinoma
    Jaeger, HJ
    Mehring, UM
    Castaneda, F
    Hasse, F
    Blumhardt, G
    Loehlein, D
    Mathias, KD
    CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY, 1996, 19 (06) : 388 - 396
  • [33] Early prediction of survival in hepatocellular carcinoma patients treated with transarterial chemoembolization plus sorafenib
    Xiao-Chun Meng
    Bing-Hui Chen
    Jing-Jun Huang
    Wen-Sou Huang
    Ming-Yue Cai
    Jing-Wen Zhou
    Yong-Jian Guo
    Kang-Shun Zhu
    World Journal of Gastroenterology, 2018, (04) : 484 - 493
  • [34] Early prediction of survival in hepatocellular carcinoma patients treated with transarterial chemoembolization plus sorafenib
    Meng, Xiao-Chun
    Chen, Bing-Hui
    Huang, Jing-Jun
    Huang, Wen-Sou
    Cai, Ming-Yue
    Zhou, Jing-Wen
    Guo, Yong-Jian
    Zhu, Kang-Shun
    WORLD JOURNAL OF GASTROENTEROLOGY, 2018, 24 (04) : 484 - 493
  • [35] SORAFENIB WITH OR WITHOUT TRANSARTERIAL CHEMOEMBOLIZATION PLUS RADIOFREQUENCY ABLATION FOR ADVANCED RECURRENT HEPATOCELLULAR CARCINOMA
    Xiao, Han
    Zhang, Ning
    Xu, Lixia
    Kuang, Ming
    GASTROENTEROLOGY, 2018, 154 (06) : S1236 - S1236
  • [36] Raltitrexed plus oxaliplatin-based transarterial chemoembolization in patients with unresectable hepatocellular carcinoma
    Zhao, Chang
    Fan, Liwei
    Qi, Feng
    Ou, Shengqiu
    Yu, Lei
    Yi, Xiaoyu
    Ni, Bingqiang
    Zheng, Zhiyong
    Lu, Jianxun
    Zhang, Chengwen
    Cheng, Changsheng
    Lu, Xiong
    Cheng, Lin
    Hu, Tianlian
    Ma, Yilong
    ANTI-CANCER DRUGS, 2016, 27 (07) : 689 - 694
  • [37] Efficacy of Drug-Eluting Beads Transarterial Chemoembolization Plus Camrelizumab Compared With Conventional Transarterial Chemoembolization Plus Camrelizumab for Unresectable Hepatocellular Carcinoma
    Ren, Yanqiao
    Guo, Yusheng
    Chen, Lei
    Sun, Tao
    Zhang, Weihua
    Sun, Bo
    Zhu, Licheng
    Xiong, Fu
    Zheng, Chuansheng
    CANCER CONTROL, 2022, 29
  • [38] Efficacy of Drug-Eluting Beads Transarterial Chemoembolization Plus Camrelizumab Compared With Conventional Transarterial Chemoembolization Plus Camrelizumab for Unresectable Hepatocellular Carcinoma
    Ren, Yanqiao
    Guo, Yusheng
    Chen, Lei
    Sun, Tao
    Zhang, Weihua
    Sun, Bo
    Zhu, Licheng
    Xiong, Fu
    Zheng, Chuansheng
    CANCER CONTROL, 2022, 29
  • [39] Efficacy of Drug-Eluting Beads Transarterial Chemoembolization Plus Camrelizumab Compared With Conventional Transarterial Chemoembolization Plus Camrelizumab for Unresectable Hepatocellular Carcinoma
    Ren, Yanqiao
    Guo, Yusheng
    Chen, Lei
    Sun, Tao
    Zhang, Weihua
    Sun, Bo
    Zhu, Licheng
    Xiong, Fu
    Zheng, Chuansheng
    CANCER CONTROL, 2022, 29
  • [40] Identifying optimal candidates of transarterial chemoembolization (TACE) vs. sorafenib in patients with unresectable hepatocellular carcinoma
    Zhao, Shoujie
    Dou, Weijia
    Fan, Qingling
    Hu, Jie
    Li, Huichen
    Zhang, Xiangnan
    Zhang, Qian
    Liu, Lei
    ANNALS OF TRANSLATIONAL MEDICINE, 2020, 8 (09)
12345